Pharmaceutical Partnering and Alliances

Previous Page 1 of 10 Next >

Search returned 97 items.

sort by: Title | Author | Publication | Date

Japanese Drug Company Bids for U.S. Biotech Firm

The $25-a-share deal, announced Thursday, represented a 53 percent premium to Millennium's closing price Wednesday, and it immediately set off speculation that...

Date: 04/11/2008 , Publication: NY TIMES , Author: ANDREW POLLACK

http://www.nytimes.com/2008/04/11/business/worldbusiness/11drug.html?ref=health

Drug company ties common in med schools

Two-thirds of academic leaders have financial links to industry, study says

Date: 10/16/2007 , Publication: MSNBC , Author: Associated Press

http://www.msnbc.msn.com/id/21333262/

Tibotec Gets AIDS

With a new wave of "resistant to resistance" HIV drugs, a record of consistent innovation, and a dynamic partnership with AIDS activists, J&J's little company is in it to win it. And end it.

Date: 07/30/2007 , Publication: Pharmaceutical Executive , Author: Walter Armstrong

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=446937

Deals: Roche Goes Shopping

BioVeris purchase locks in a key diagnostic technology. PLUS: Eisai buys Morphotek, IMS gets more outcomes-research muscle, and other top deals.

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Pharmaceutical Executive

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423197

Critical Mass for Critical Path?

...the rewards of collaboration now look greater than the risks....

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Dan Weiner, Mark Hovde

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423202

Make It New

To fix pharma's business model, nothing less than big, bold, and risky fits the bill. Two radical new visions focus on getting back to...

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Walter Armstrong

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=418775

Toolkit: How To Be a Better Partner

Big pharmas and little biotechs have been getting hitched for years. Now it's time to add a little innovation to the relationship.

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Waseem Noor

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423200

Thought Leader: Joseph Brindisi, Kyowa Pharmaceuticals

Rethinking Partnership

Date: 03/01/2007 , Publication: Pharmaceutical Executive , Author: Pharmaceutical Executive

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=408470

Merger and Acquisition Drivers Remain in Place for 2007

Deals will continue to remake the pharmaceutical services landscape in 2007.

Date: 02/01/2007 , Publication: Pharmaceutical Technology , Author: Jim Miller

http://www.pharmtech.com/pharmtech/article/articleDetail.jsp?id=400648

Driven to License

The new trend in business development is licensing deals and acquisitions. The hot categories are CNS, oncology, and immunology.

Date: 02/01/2007 , Publication: Pharmaceutical Executive , Author: Ben Bonifant, Michael Dombeck, Alex Lugovoy

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=401667

Previous Page 1 of 10 Next >

Search returned 97 items.